About Innosyn Life Sciences
Innosyn Life Sciences is a Healthcare company based in Hyderabad (India). Synthesis of pharmaceutical intermediates and provision of custom services in life sciences. It operates in the Healthcare and Chemicals & Materials sectors. The company has 9 employees. Its Indian entity Innosyn Life Sciences Private Limited reported revenue of ₹3.04 Cr. Innosyn Life Sciences offers products and services including Heterocyclic Building Blocks and Custom Synthesis Services. Its focus areas include Pharmaceuticals, Research Chemicals, Intermediates and Chemicals.
Company details
Innosyn Life Sciences is identified as a provider of molecule synthesis and supply, with cost-effective approaches being utilized to assist companies in achieving success. Close collaboration with clients is employed to understand their requirements and deliver time-bound solutions, focusing on reference materials, research chemicals, and RD services. A commitment to process development and commercial production is maintained to ensure high-quality products for research needs, aiming to position the company as a preferred partner in the global pharma industry. Discounts on bulk quantities are also offered to support customer needs.
- Headquarters Hyderabad, India
- Employees 9
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Legal Name Innosyn Life Sciences Pvt. Ltd
- Date of Incorporation 27 Jun, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹3.04 Cr
FY 2025 · +26% YoY
- Net Profit₹2.3 Lakh
FY 2025 · 1% margin
- EBITDA₹34 Lakh
FY 2025 · 11% margin
- Employee Count9
Associated legal entities of Innosyn Life Sciences
Innosyn Life Sciences operates through Innosyn Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Innosyn Life Sciences Private Limited CIN U74999TG2017PTC117973 | Active | 27 Jun 2017 | Hyderabad, Telangana | ₹3.0 Cr | 9 | 2 | View details |
Products & Services of Innosyn Life Sciences
Innosyn Life Sciences offers a comprehensive portfolio of products and services, including Heterocyclic Building Blocks and Custom Synthesis Services.
These building blocks are supplied for pharmaceutical applications and research purposes.
These services are provided for API intermediates and other compounds on various scales.
Board of directors of Innosyn Life Sciences Private Limited (Innosyn Life Sciences)
Innosyn Life Sciences Private Limited is the primary company behind Innosyn Life Sciences. The board of Innosyn Life Sciences Private Limited currently have 2 directors; the longest-serving is Ramesh Babu Anagani, appointed in 2017. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramesh Babu Anagani DIN 07847030 | Managing Director | 27 Jun 2017 | 9 yrs 3 mo | Innosyn Life Sciences Private Limited |
| Shilpa Gudibandla DIN 07847035 | Director | 27 Jun 2017 | 9 yrs 3 mo | Innosyn Life Sciences Private Limited |
Financials of Innosyn Life Sciences
Figures of Innosyn Life Sciences Private Limited, the primary company behind Innosyn Life Sciences, for FY 2025. Revenue was ₹3.04 Cr (+26% year on year). Net profit was ₹2.3 Lakh (1% margin). EBITDA was ₹34 Lakh (11% margin). Revenue has grown at a compounded annual rate of +7% over three years and +29% over five years.
- ₹3.04 CrRevenue · FY 2025 · +26% YoY
- ₹2.3 LakhNet profit · 1% margin
- ₹34 LakhEBITDA · 11% margin
- ₹1 LakhPaid-up capital
- 9Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +29%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Innosyn Life Sciences Private Limited are on its company page.
Detailed financial statements for Innosyn Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Innosyn Life Sciences
Innosyn Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Innosyn Life Sciences has 9 employees.
The primary company behind Innosyn Life Sciences, Innosyn Life Sciences Private Limited, reported revenue of ₹3.04 Cr for FY 2025, up 26% year on year.
Innosyn Life Sciences is identified as a provider of molecule synthesis and supply, with cost-effective approaches being utilized to assist companies in achieving success. Close collaboration with clients is employed to understand their requirements and deliver time-bound solutions, focusing on reference materials, research chemicals, and RD services. A commitment to process development and commercial production is maintained to ensure high-quality products for research needs, aiming to position the company as a preferred partner in the global pharma industry. Discounts on bulk quantities are also offered to support customer needs.
Innosyn Life Sciences offers Heterocyclic Building Blocks and Custom Synthesis Services.
Innosyn Life Sciences operates through Innosyn Life Sciences Private Limited.
The legal entities of Innosyn Life Sciences currently have 2 directors, including Ramesh Babu Anagani, Shilpa Gudibandla.